MedPath

A Trial of Treatment for Trauma-Related Nightmares in Active Duty Military Personnel

Not Applicable
Completed
Conditions
Nightmares
Interventions
Behavioral: ERRT-M for Nightmares
Registration Number
NCT02506595
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Brief Summary

The purpose of this study is to obtain preliminary data of the efficacy of Exposure, Relaxation, and Rescripting Therapy for nightmares among active duty military personnel.

Detailed Description

This will be a pilot randomized controlled trial to compare the effects of Exposure, Relaxation, and Rescripting Therapy for military populations (ERRT-M) among active duty service members. Participants will be randomized to 5 sessions of ERRT-M (n = 20 ) or to a 5-week waitlist control group (WL; n = 20).

Participants will complete all interviews and self-report measures 1 weeks following treatment or the WL condition and 1 month after completing treatment.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
47
Inclusion Criteria
  • Active duty military stationed at Fort Hood as assessed by self-report.
  • Able to speak and read English.
  • History of a traumatic event.
  • Nightmare Disorder
  • Stable on psychotropic and/or hypnotic medications and/or interventions for sleep (e.g., Continuous Positive Air Pressure for sleep apnea) administered by other providers for at least one month assessed by self-report and review of medical record.
  • Willingness to refrain from beginning new behavioral health or medication treatment for issues pertaining to sleep, PTSD, or nightmares during participation in the study.
  • Indication that the SM plans to be in the area for the 5 months following the first assessment
Exclusion Criteria
  • Current suicide or homicide risk meriting crisis intervention.
  • Severe brain damage, assessed by the inability to comprehend baseline questionnaires.
  • Pregnancy at baseline.
  • Serious mental health diagnosis such as bipolar disorder or psychosis, assessed with the pre-treatment health interview and review of medical record.
  • Currently taking propranolol.
  • Currently engaged in evidence-based treatment for PTSD (i.e., Prolonged Exposure Therapy or Cognitive Processing Therapy) or Insomnia (i.e., Cognitive Behavioral Therapy for Insomnia).

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
ERRT-M for NightmaresERRT-M for NightmaresExposure, Relaxation, and Rescripting Therapy Military version (ERRT-M) -
Primary Outcome Measures
NameTimeMethod
Number of nightmares reported on the Nightmare LogChange from baseline to 2-week posttreatment
Secondary Outcome Measures
NameTimeMethod
Total score on the Insomnia Severity Index (ISI)Change from baseline to 2-week posttreatment
Total score on the Clinician Administered PTSD Scale (CAPS-5)Change from baseline to 2-week posttreatment
Total score on the PTSD Checklist -DSM-5 (PCL-5)Change from baseline to 2-week posttreatment
Total score on the Patient Health Questionnaire (PHQ-9)Change from baseline to 2-week posttreatment

Trial Locations

Locations (1)

Carl R Darnall Army Medical Center

🇺🇸

Fort Hood, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath